Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer

J Ferlay, M Colombet, I Soerjomataram, R Siegel, L Torre, A Jemal

2018-01-01

Abstract:

What problem does this paper attempt to address?

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, RL Siegel, LA Torre, A Jemal

2020-07-01

Abstract:
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

J. Ferlay,M. Colombet,I. Soerjomataram,C. Mathers,D.M. Parkin,M. Piñeros,A. Znaor,F. Bray

DOI: https://doi.org/10.1002/ijc.31937

2018-12-06

International Journal of Cancer

Abstract:Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex- and site-specific all-ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5-18.7 million) new cases of cancer (17 million excluding non-melanoma skin cancer) and 9.6 million (95% UI: 9.3-9.8 million) deaths from cancer (9.5 million excluding non-melanoma skin cancer) worldwide in 2018.

oncology
Global Cancer Statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2020

H Sung, J Ferlay, RL Siegel, M Laversanne, I Soerjomataram, A Jemal, F Bray

Abstract:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Global Cancer Statistics 2020

H Sung, J Ferlay, RL Siegel, M Laversanne, I Soerjomataram, A Jemal, F Bray

2021-01-01

Abstract:
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sun, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray

2021-05-01

Abstract:
Global Cancer Statis-tics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Can-cer Journal for Clinicians, 71, 209-249

H Sung, J Ferlay, RL Siegel, M Laversanne, I Soerjomataram, A Jemal, F Bray

2021-01-01

Abstract:
Estadísticas mundiales de cáncer 2018: estimaciones de GLOBOCAN de incidencia y mortalidad en todo el mundo para 36 cánceres en 185 países

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal

2018-11-01

Abstract:
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray

DOI: https://doi.org/10.1002/ijc.29210

2014-10-09

International Journal of Cancer

Abstract:Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large "areas" of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).

oncology
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay,Hai‐Rim Shin,Freddie Bray,David Forman,Colin Mathers,Donald Maxwell Parkin,Hai-Rim Shin

DOI: https://doi.org/10.1002/ijc.25516

2010-06-17

International Journal of Cancer

Abstract:Estimates of the worldwide incidence and mortality from 27 cancers in 2008 have been prepared for 182 countries as part of the GLOBOCAN series published by the International Agency for Research on Cancer. In this article, we present the results for 20 world regions, summarizing the global patterns for the eight most common cancers. Overall, an estimated 12.7 million new cancer cases and 7.6 million cancer deaths occur in 2008, with 56% of new cancer cases and 63% of the cancer deaths occurring in the less developed regions of the world. The most commonly diagnosed cancers worldwide are lung (1.61 million, 12.7% of the total), breast (1.38 million, 10.9%) and colorectal cancers (1.23 million, 9.7%). The most common causes of cancer death are lung cancer (1.38 million, 18.2% of the total), stomach cancer (738,000 deaths, 9.7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high-resource countries. Striking differences in the patterns of cancer from region to region are observed.

oncology
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,Rebecca L. Siegel,Lindsey A. Torre,Ahmedin Jemal

DOI: https://doi.org/10.3322/caac.21492

2018-09-12

Abstract:This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.

oncology
Cancer statistics for the year 2020: An overview

Jacques Ferlay,Murielle Colombet,Isabelle Soerjomataram,Donald M. Parkin,Marion Piñeros,Ariana Znaor,Freddie Bray

DOI: https://doi.org/10.1002/ijc.33588

2021-04-22

International Journal of Cancer

Abstract:<p>This paper briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020, and summarises the main results. National estimates were calculated based on the best available data on cancer incidence from population‐based cancer registries (PBCR) and mortality from the World Health Organization (WHO) mortality database. Cancer incidence and mortality rates for 2020 by sex and age groups were estimated for 38 cancer sites and 185 countries or territories worldwide. There were an estimated 19.3 million (95% UI: 19.0‐19.6 million) new cases of cancer (18.1 million excluding non‐melanoma skin cancer) and almost 10.0 million (95% UI: 9.7‐10.2 million) deaths from cancer (9.9 million excluding non‐melanoma skin cancer) worldwide in 2020. The most commonly‐diagnosed cancers worldwide were female breast cancer (2.26 million cases), lung (2.21) and prostate cancers (1.41); the most common causes of cancer death were lung (1.79 million deaths), liver (830,000) and stomach cancers (769,000).</p><p>This article is protected by copyright. All rights reserved.</p>

oncology
CA A cancer J clinicians-2021-sung-global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality

H Sung, J Ferlay, RL Siegel, M Laversanne, I Soerjomataram, A Jemal

2021-01-01

Abstract:
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray,Mathieu Laversanne,Hyuna Sung,Jacques Ferlay,Rebecca L. Siegel,Isabelle Soerjomataram,Ahmedin Jemal

DOI: https://doi.org/10.3322/caac.21834

2024-04-06

CA A Cancer Journal for Clinicians

Abstract:This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four‐fold to five‐fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South‐Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics‐based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.

oncology
The global burden of cancer 2013

Christina Fitzmaurice, Daniel Dicker, Amanda Pain, Hannah Hamavid, Maziar Moradi-Lakeh, Michael F MacIntyre, Christine Allen, Gillian Hansen, Rachel Woodbrook, Charles Wolfe, Randah R Hamadeh, Ami Moore, Andrea Werdecker, Bradford D Gessner, Braden Te Ao, Brian McMahon, Chante Karimkhani, Chuanhua Yu, Graham S Cooke, David C Schwebel, David O Carpenter, David M Pereira, Denis Nash, Dhruv S Kazi, Diego De Leo, Dietrich Plass, Kingsley N Ukwaja, George D Thurston, Kim Yun Jin, Edgar P Simard, Edward Mills, Eun-Kee Park, Ferrán Catalá-López, Gabrielle DeVeber, Carolyn Gotay, Gulfaraz Khan, H Dean Hosgood, Itamar S Santos, Janet L Leasher, Jasvinder Singh, James Leigh, Jost B Jonas, Juan Sanabria, Justin Beardsley, Kathryn H Jacobsen, Ken Takahashi, Richard C Franklin, Luca Ronfani, Marcella Montico, Luigi Naldi, Marcello Tonelli, Johanna Geleijnse, Max Petzold, Mark G Shrime, Mustafa Younis, Naohiro Yonemoto, Nicholas Breitborde, Paul Yip, Farshad Pourmalek, Paulo A Lotufo, Alireza Esteghamati, Graeme J Hankey, Raghib Ali, Raimundas Lunevicius, Reza Malekzadeh, Robert Dellavalle, Robert Weintraub, Robyn Lucas, Roderick Hay, David Rojas-Rueda, Ronny Westerman, Sadaf G Sepanlou, Sandra Nolte, Scott Patten, Scott Weichenthal, Semaw Ferede Abera, Seyed-Mohammad Fereshtehnejad, Ivy Shiue, Tim Driscoll, Tommi Vasankari, Ubai Alsharif, Vafa Rahimi-Movaghar, Vasiliy V Vlassov, WS Marcenes, Wubegzier Mekonnen, Yohannes Adama Melaku, Yuichiro Yano, Al Artaman, Ismael Campos, Jennifer MacLachlan, Ulrich Mueller, Daniel Kim, Matias Trillini, Babak Eshrati, Hywel C Williams, Kenji Shibuya, Rakhi Dandona, Kinnari Murthy, Benjamin Cowie, Azmeraw T Amare, Carl Abelardo Antonio, Carlos Castañeda-Orjuela, Coen H Van Gool, Francesco Violante, In-Hwan Oh, Kedede Deribe, Kjetil Soreide, Luke Knibbs, Maia Kereselidze, Mark Green, Rosario Cardenas, Nobhojit Roy, Taavi Tillmann, Yongmei Li, Hans Krueger, Lorenzo Monasta, Subhojit Dey, Sara Sheikhbahaei, Nima Hafezi-Nejad, G Anil Kumar, Chandrashekhar T Sreeramareddy, Lalit Dandona, Haidong Wang, Stein Emil Vollset, Ali Mokdad, Joshua A Salomon, Rafael Lozano, Theo Vos, Mohammad Forouzanfar, Alan Lopez, Christopher Murray, Mohsen Naghavi, Global Burden of Disease Cancer Collaboration

2015-07-01

Abstract:ImportanceCancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.ObjectiveTo estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013.Evidence ReviewThe general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data …
Global cancer facts and figures 2011

M Garcia, A Jemal, E Ward

2011-01-01

Abstract:
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

Isabelle Soerjomataram,Joannie Lortet-Tieulent,D Maxwell Parkin,Jacques Ferlay,Colin Mathers,David Forman,Freddie Bray

DOI: https://doi.org/10.1016/S0140-6736(12)60919-2

2012-11-24

Abstract:Background: Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008. Methods: We used population-based data, mostly from cancer registries, for incidence, mortality, life expectancy, disease duration, and age at onset and death, alongside proportions of patients who were treated and living with sequelae or regarded as cured, to calculate years of life lost (YLLs) and years lived with disability (YLDs). We used YLLs and YLDs to derive DALYs for 27 sites of cancers in 184 countries in 12 world regions. Estimates were grouped into four categories based on a country's human development index (HDI). We applied zero discounting and uniform age weighting, and age-standardised rates to enable cross-country and regional comparisons. Findings: Worldwide, an estimated 169·3 million years of healthy life were lost because of cancer in 2008. Colorectal, lung, breast, and prostate cancers were the main contributors to total DALYs in most world regions and caused 18-50% of the total cancer burden. We estimated an additional burden of 25% from infection-related cancers (liver, stomach, and cervical) in sub-Saharan Africa, and 27% in eastern Asia. We noted substantial global differences in the cancer profile of DALYs by country and region; however, YLLs were the most important component of DALYs in all countries and for all cancers, and contributed to more than 90% of the total burden. Nonetheless, low-resource settings had consistently higher YLLs (as a proportion of total DALYs) than did high-resource settings. Interpretation: Age-adjusted DALYs lost from cancer are substantial, irrespective of world region. The consistently larger proportions of YLLs in low HDI than in high HDI countries indicate substantial inequalities in prognosis after diagnosis, related to degree of human development. Therefore, radical improvement in cancer care is needed in low-resource countries. Funding: Dutch Scientific Society, Erasmus University Rotterdam, and International Agency for research on Cancer.
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020

Citadel J. Cabasag,Paula J. Fagan,Jacques Ferlay,Jerome Vignat,Mathieu Laversanne,Lihua Liu,Maaike A. Aa,Freddie Bray,Isabelle Soerjomataram

DOI: https://doi.org/10.1002/ijc.34002

2022-03-30

International Journal of Cancer

Abstract:International Journal of Cancer, Accepted Article.

oncology
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

Eileen Morgan,Melina Arnold,A Gini,V Lorenzoni,C J Cabasag,Mathieu Laversanne,Jerome Vignat,Jacques Ferlay,Neil Murphy,Freddie Bray

DOI: https://doi.org/10.1136/gutjnl-2022-327736

IF: 24.5

Gut

Abstract:Objective: Colorectal cancer (CRC) is the third most common cancer worldwide. The geographical and temporal burden of this cancer provides insights into risk factor prevalence and progress in cancer control strategies. We examine the current and future burden of CRC in 185 countries in 2020 and 2040. Methods: Data on CRC cases and deaths were extracted from the GLOBOCAN database for the year 2020. Age-standardised incidence and mortality rates were calculated by sex, country, world region and Human Development Index (HDI) for 185 countries. Age-specific rates were also estimated. The predicted number of cases and deaths in 2040 were calculated based on global demographic projections by HDI. Results: Over 1.9 million new CRC cases and 930 000 deaths were estimated in 2020. Incidence rates were highest in Australia/ New Zealand and European regions (40.6 per 100 000, males) and lowest in several African regions and Southern Asia (4.4 per 100 000, females). Similar patterns were observed for mortality rates, with the highest observed in Eastern Europe (20.2 per 100 000, males) and the lowest in Southern Asia (2.5 per 100 000, females). The burden of CRC is projected to increase to 3.2 million new cases and 1.6 million deaths by 2040 with most cases predicted to occur in high or very high HDI countries. Conclusions: CRC is a highly frequent cancer worldwide, and largely preventable through changes in modifiable risk factors, alongside the detection and removal of precancerous lesions. With increasing rates in transitioning countries and younger adults, there is a pressing need to better understand and act on findings to avert future cases and deaths from the disease.

Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Global Cancer Statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2020

GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Global Cancer Statistics 2020

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global Cancer Statis-tics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Can-cer Journal for Clinicians, 71, 209-249

Estadísticas mundiales de cáncer 2018: estimaciones de GLOBOCAN de incidencia y mortalidad en todo el mundo para 36 cánceres en 185 países

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Cancer statistics for the year 2020: An overview

CA A cancer J clinicians-2021-sung-global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

The global burden of cancer 2013

Global cancer facts and figures 2011

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020

Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN